Vogenx Inc. (VOGX)
Last updated: 2026-10-21 17:19:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Vogenx Inc. (VOGX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $20.30, with a market capitalization of $236.49M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $12.95 to $38.41. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$236.49M | |
$18.98 | |
$38.41 | |
$12.95 | |
$18.75 | |
38.46K | |
173.13K | |
-- | |
$38.41 | |
$12.95 | |
-- | |
-- |
Vogenx Inc. (VOGX) Stock Price Today
Vogenx Inc. (VOGX) is currently trading at $20.30 as of 2026-10-21 17:17:00, up 8.25% ($1.55) from the previous close of $18.75
During today's regular trading session, VOGX has traded between $12.95 and $38.41, with a trading volume of 38.46K shares. The current price is near the lower end of today's range.
Vogenx Inc. (VOGX) 7-Day Stock Price Change
Over the past seven days, Vogenx Inc. (VOGX) moved from $17.14 to $20.30, representing a gain of 18.41% ($3.16).
The stock traded between $14.25 and $21.90 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 101.40 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
VOGX 52-Week Price Position
Position in Range: 28.9%
VOGX is currently trading at $20.30, placing it 28.9% of the way from its 52-week low of $12.95 to its 52-week high of $38.41. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Vogenx Inc. (VOGX)?
Vogenx Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia, or PBH, and gastroparesis. The company's flagship product candidate, mizagliflozin, is an orally administered, minimally absorbed, small molecule drug candidate being developed for the treatment of post-bariatric hypoglycemia (PBH), gastroparesis and GIP-induced Cushing's Syndrome. It operates as a single reportable segment engaged in the discovery and development of treatments for serious metabolic and gastrointestinal diseases.
Vogenx Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 5 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Vogenx Inc. (VOGX) Stock on MEXC
Eligible investors can buy real shares of Vogenx Inc. (VOGX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Vogenx Inc. (VOGX) stock price today?
2.Is VOGX stock going up or down today?
3.What is VOGX pre-market price?
4.What is VOGX after-hours price?
5.Is VOGX stock trading now?
6.Where does VOGX sit relative to its 52-week high and low?
7.What sector is Vogenx Inc. in?
8.What is Vogenx Inc.'s market capitalization and where is it listed?
9.How is VOGX valued in terms of P/E ratio and EPS?
10.Does Vogenx Inc. pay a dividend?
Explore More US Stocks
Search Stocks
VOGX Stock Calculator
Estimate the value between VOGX shares and USD.
VOGX Shares to USD
1.00 VOGX shares = 20.296 USD
Calculations are estimates based on the latest available price and are for reference only.


